Legacy Education (LGCY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 Mar, 2026Company overview and market positioning
Operates six campuses in California, focusing on affordable, accredited post-secondary education in allied healthcare, veterinary, and business fields, with 3,234 students enrolled as of December 31, 2025.
Programs are designed for high ROI, shorter durations, and strong job placement, with a 79% graduation rate and 75% placement rate.
Strategic growth through organic enrollment, new program development, and accretive acquisitions, with a 28% five-year enrollment CAGR.
Leadership team averages over 20 years of industry experience, supporting operational stability and growth.
Financial performance and key metrics
Achieved $75.1M in LTM revenue (42% YoY growth) and $12.4M LTM adjusted EBITDA, maintaining a 17% margin.
Ended Q2 FY26 with $21.1M in cash, $27.8M working capital, and $179M market capitalization.
Student acquisition cost is $1.5K, generating over 15x annual revenue per student ($25.0K).
Quarterly enrollment and starts have shown consistent growth, with a 17% YoY increase in student population.
Academic outcomes and program expansion
82% NCLEX pass rate and 75% average placement rate across campuses as of June 30, 2025.
Top five programs by enrollment represent 64% of total enrollment, emphasizing healthcare and allied health fields.
Continuous program innovation, including new offerings in nursing, imaging, veterinary, and dental fields.
Hybrid and interactive distance learning models implemented, with 30–50% of students enrolled via IDL.
Latest events from Legacy Education
- Record enrollment lifted revenue, while growth costs and a legal settlement cut earnings.LGCY
Q1 2027 - Six director nominees and the FY2027 auditor appointment go before shareholders.LGCY
Proxy filing - Six directors and the auditor face votes at a virtual Dec. 15, 2026 meeting.LGCY
Proxy filing - Achieved 33% revenue and 45% enrollment growth in 2024, driven by healthcare program expansion.LGCY
Investor presentation - Record revenue, margin, and enrollment gains set the stage for growth via new programs and expansion.LGCY
Q4 2026 - 32% revenue growth and strong student outcomes drive expansion in accredited healthcare education.LGCY
Investor presentation - Q3 2026 revenue up 15% and net income up 7.5%, driven by enrollment and new programs.LGCY
Q3 2026 - Q2 revenue up 40.7% and net income up 46%, driven by enrollment and acquisition growth.LGCY
Q2 2026 - Q3 revenue rose 50.7% and enrollment 49.8%, driven by CCMCC acquisition and strong demand.LGCY
Q3 2025